Simulations Plus Inc Market Cap ($372.54 Million)
Market Cap & Net Worth: Simulations Plus Inc (SLP)
Simulations Plus Inc market cap. Simulations Plus Inc (NASDAQ:SLP) has a market capitalization of $372.54 Million ($372.54 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13493 globally and #3282 in its home market, demonstrating a 0.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Simulations Plus Inc's stock price $18.50 by its total outstanding shares 20224838 (20.22 Million). Also see Simulations Plus Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Simulations Plus Inc Market Cap History (2015–2026)
Simulations Plus Inc market cap history from 2015 to 2026. Data shows growth from $183.95 Million to $374.16 Million (7.14% CAGR). Check SLP live share price for real-time trading data and today's change.
Index Memberships
Simulations Plus Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #1325 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.55 Trillion | 0.04% | #556 of 602 |
Weight: Simulations Plus Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Simulations Plus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Simulations Plus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Simulations Plus Inc (SLP) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.66x
Simulations Plus Inc's market cap is 4.66 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $183.15 Million | $18.31 Million | $3.84 Million | 10.00x | 47.66x |
| 2017 | $310.45 Million | $24.14 Million | $5.79 Million | 12.86x | 53.64x |
| 2018 | $388.88 Million | $29.67 Million | $8.93 Million | 13.11x | 43.52x |
| 2019 | $573.41 Million | $33.97 Million | $8.58 Million | 16.88x | 66.81x |
| 2020 | $1.43 Billion | $41.59 Million | $9.33 Million | 34.28x | 152.78x |
| 2021 | $941.94 Million | $46.47 Million | $9.78 Million | 20.27x | 96.29x |
| 2022 | $732.06 Million | $53.91 Million | $12.48 Million | 13.58x | 58.64x |
| 2023 | $901.12 Million | $59.58 Million | $9.96 Million | 15.13x | 90.46x |
| 2024 | $564.07 Million | $70.01 Million | $9.95 Million | 8.06x | 56.67x |
| 2025 | $368.70 Million | $79.18 Million | -$64.72 Million | 4.66x | N/A |
Competitor Companies of SLP by Market Capitalization
Companies near Simulations Plus Inc in the global market cap rankings as of November 5, 2026. Also see SLP total asset value for a full breakdown of the balance sheet.
Key companies related to Simulations Plus Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #725 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1696 globally with a market cap of $13.94 Billion USD ( AU$19.71 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2023 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2082 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #725 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $310.63 |
| #1696 | Pro Medicus Ltd | AU:PME | $13.94 Billion | AU$188.64 |
| #2023 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $75.61 |
| #2082 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $69.80 |
Market Capitalization of Simulations Plus Inc (2015–2026)
Market capitalization of Simulations Plus Inc from 2015 to today. Between 2015 and today, Simulations Plus Inc's market cap moved from $183.95 Million to $ 374.16 Million, with a yearly change of 7.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $374.16 Million | +1.48% |
| 2025 | $368.70 Million | -34.64% |
| 2024 | $564.07 Million | -37.40% |
| 2023 | $901.12 Million | +23.09% |
| 2022 | $732.06 Million | -22.28% |
| 2021 | $941.94 Million | -33.93% |
| 2020 | $1.43 Billion | +148.64% |
| 2019 | $573.41 Million | +47.45% |
| 2018 | $388.88 Million | +25.26% |
| 2017 | $310.45 Million | +69.51% |
| 2016 | $183.15 Million | -0.44% |
| 2015 | $183.95 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Simulations Plus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $372.54 Million USD |
| MoneyControl | $372.54 Million USD |
| MarketWatch | $372.54 Million USD |
| marketcap.company | $372.54 Million USD |
| Reuters | $372.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans… Read more